Autologous and allogeneic HLA KIR ligand environments and activating KIR control KIR NK-cell functions

European Journal of Immunology

Volumn 38, Issue 12, 2008, Pages 3474-3486

  Morvan, Maelig ^a   David, Gaëlle ^a   Sébille, Véronique ^a   Perrin, Aurore ^a   Gagne, Katia ^a   Willem, Catherine ^a   Kerdudou, Nolwenn ^a   Denis, Laure ^a   Clémenceau, Béatrice ^a   Folléa, Gilles ^a   Bignon, Jean Denis ^a   Retière, Christelle ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

HLA class I molecules; Killer cell immunoglobulin like receptors; NK cells; NK repertoire

Indexed keywords

GAMMA INTERFERON; HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MONOCLONAL ANTIBODY; HLA ANTIGEN; LIGAND;

ALLOIMMUNITY; ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL EXPANSION; CELL FUNCTION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL; REGULATORY MECHANISM; AUTOIMMUNITY; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; EPSTEIN BARR VIRUS; IMMUNOLOGY; PROTEIN BINDING;

AUTOIMMUNITY; CELL DIFFERENTIATION; CELLS, CULTURED; GENOTYPE; HERPESVIRUS 4, HUMAN; HLA ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LIGANDS; PROTEIN BINDING; RECEPTORS, KIR;

EID: 59749103164     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200838407     Document Type: Article

References (37)

1. Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S. et al., Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002. 295: 2097-2100.
2. Gagne, K., Busson, M., Balere-Appert, M. L., Absi, L., Jollet, I., Bignon, J. D., Bois, M. et al., Relevance of KIR gene matching in unrelated hematopoietic stem cell transplantations. Tissue Antigens 2007. 69: 118-122.
3. Bignon, J. D. and Gagne, K., KIR matching in hematopoietic stem cell transplantation. Curr. Opin. Immunol. 2005. 17: 553-559.
4. Ljunggren, H. G. and Karre, K., In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 1990. 11: 237-244.
5. Willcox, B. E., Thomas, L. M. and Bjorkman, P. J., Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nat. Immunol. 2003. 4: 913-919.
6. Braud, V. M., Allan, D. S., O'Callaghan, C. A., Soderstrom, K., D'Andrea, A., Ogg, G. S., Lazetic, S. et al., HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998. 391: 795-799.
7. Moretta, L. and Moretta, A., Killer immunoglobulin-like receptors. Curr. Opin. Immunol. 2004. 16: 626-633.
8. Moretta, A., Sivori, S., Vitale, M., Pende, D., Morelli, L., Augugliaro, R., Bottino, C. and Moretta, L., Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J. Exp. Med. 1995. 182: 875-884.
9. Stewart, C. A., Laugier-Anfossi, F., Vely, F., Saulquin, X., Riedmuller, J., Tisserant, A., Gauthier, L. et al., Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc. Natl. Acad. Sci. USA 2005. 102: 13224-13229.
10. Chewning, J. H., Gudme, C. N., Hsu, K. C., Selvakumar, A. and Dupont, B., KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro. J. Immunol. 2007. 179: 854-868.
11. Foley, B., De Santis, D., Lathbury, L., Christiansen, F. and Witt, C., KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals. Int. Immunol. 2008. 4: 555-563.
12. Vivier, E. and Daeron, M., Immunoreceptor tyrosine-based inhibition motifs. Immunol. Today 1997. 18: 286-291.
13. Vely, F. and Vivier, E., Conservation of structural features reveals the existence of a large family of inhibitory cell surface receptors and noninhibitory/activatory counterparts. J. Immunol. 1997. 159: 2075-2077.
14. Valiante, N. M., Uhrberg, M., Shilling, H. G., Lienert-Weidenbach, K., Arnett, K. L., D'Andrea, A., Phillips, J. H. et al., Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 1997. 7: 739-751.
15. Uhrberg, M., Valiante, N. M., Shum, B. P., Shilling, H. G., Lienert-Weidenbach, K., Corliss, B., Tyan, D. et al., Human diversity in killer cell inhibitory receptor genes. Immunity 1997. 7: 753-763.
16. Kim, S., Poursine-Laurent, J., Truscott, S. M., Lybarger, L., Song, Y. J., Yang, L., French, A. R. et al., Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005. 436: 709-713.
17. Anfossi, N., Andre, P., Guia, S., Falk, C. S., Roetynck, S., Stewart, C. A., Breso, V. et al., Human NK cell education by inhibitory receptors for MHC class I. Immunity 2006. 25: 331-342.
18. Chen, C., Busson, M., Rocha, V., Appert, M. L., Lepage, V., Dulphy, N., Haas, P. et al., Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders. Bone Marrow Transplant. 2006. 38: 437-444.
19. Cook, M. A., Milligan, D. W., Fegan, C. D., Darbyshire, P. J., Mahendra, P., Craddock, C. F., Moss, P. A. and Briggs, D. C., The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood 2004. 103: 1521-1526.
20. McQueen, K. L., Dorighi, K. M., Guethlein, L. A., Wong, R., Sanjanwala, B. and Parham, P., Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation. Hum. Immunol. 2007. 68: 309-323.
21. Giebel, S., Nowak, I., Wojnar, J., Markiewicz, M., Dziaczkowska, J., Wylezol, I., Krawczyk-Kulis, M. et al., Impact of activating killer immunoglobulin-like receptor genotype on outcome of unrelated donor-hematopoietic cell transplantation. Transplant. Proc. 2006. 38: 287-291.
22. Kroger, N., Binder, T., Zabelina, T., Wolschke, C., Schieder, H., Renges, H., Ayuk, F. et al., Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantation. Transplantation 2006. 82: 1024-1030.
23. Verheyden, S., Schots, R., Duquet, W. and Demanet, C., A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation. Leukemia 2005. 19: 1446-1451.
24. Walzer, T., Jaeger, S., Chaix, J. and Vivier, E. Natural killer cells: From CD3(-)NKp46(+) to post-genomics meta-analyses. Curr. Opin. Immunol. 2007. 19: 365-372.
25. Parham, P., Taking license with natural killer cell maturation and repertoire development. Immunol. Rev. 2006. 214: 155-160.
26. Cooley, S., Xiao, F., Pitt, M., Gleason, M., McCullar, V., Bergemann, T. L., McQueen, K. L. et al., A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature. Blood 2007. 110: 578-586.
27. Igarashi, T., Wynberg, J., Srinivasan, R., Becknell, B., McCoy, J. P., Jr., Takahashi, Y., Suffredini, D. A. et al., Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells. Blood 2004. 104: 170-177.
28. Grzywacz, B., Dlubek, D. and Lange, A., NK cells become Ki-67+in MLC and expand depending on the lack of ligand for KIR on stimulator cells in IL-2 supplemented MLC. Hum. Immunol. 2002. 63: 638-646.
29. Pappworth, I. Y., Wang, E. C. and Rowe, M., The switch from latent to productive infection in Epstein-Barr virus-infected B cells is associated with sensitization to NK cell killing. J. Virol. 2007. 81: 474-482.
30. Boyton, R. J. and Altmann, D. M., Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin. Exp. Immunol. 2007. 149: 1-8.
31. Rasmussen, A. M., Smeland, E. B., Erikstein, B. K., Caignault, L. and Funderud, S., A new method for detachment of Dynabeads from positively selected B lymphocytes. J. Immunol. Methods 1992. 146: 195-202.
32. Miller, S. A., Dykes, D. D. and Polesky, H. F., A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988. 16: 1215.
33. Marsh, S. G., Parham, P., Dupont, B., Geraghty, D. E., Trowsdale, J., Middleton, D., Vilches, C. et al., Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Tissue Antigens 2003. 62: 79-86.
34. Denis, L., Sivula, J., Gourraud, P. A., Kerdudou, N., Chout, R., Ricard, C., Moisan, J. P. et al., Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Reunion. Tissue Antigens 2005. 66: 267-276.
35. Clémenceau, B., Gallot, G., Vivien, R., Gaschet, J., Campone, M. and Vie, H., Long-term preservation of antibody-dependent cellular cytotoxicity (ADCC) of natural killer cells amplified in vitro from the peripheral blood of breast cancer patients after chemotherapy. J. Immunother. 2006. 29: 53-60.
36. Akaike, H., A new look at the statistical model identification. IEEE Trans. Automat. Control 1974. AC-19: 716-723.
37. Schwarz, G., Estimating the dimension of a model. Ann. Stat. 1978. 6: 461-464.